These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 11830457

  • 1. Improved disease-free-survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia.
    Elmaagacli AH, Basoglu S, Peceny R, Trenschel R, Ottinger H, Lollert A, Runde V, Grosse-Wilde H, Beelen DW, Schaefer UW.
    Blood; 2002 Feb 15; 99(4):1130-5. PubMed ID: 11830457
    [Abstract] [Full Text] [Related]

  • 2. Outcome of transplantation of highly purified peripheral blood CD34+ cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemia.
    Elmaagacli AH, Peceny R, Steckel N, Trenschel R, Ottinger H, Grosse-Wilde H, Schaefer UW, Beelen DW.
    Blood; 2003 Jan 15; 101(2):446-53. PubMed ID: 12393406
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical sibling donors for hematological malignancies in 6064 adults from 2003 to 2020: different impacts on survival according to time period.
    Konuma T, Miyao K, Nakasone H, Ouchi F, Fukuda T, Tanaka M, Ozawa Y, Ota S, Kawakita T, Uchida N, Sawa M, Katayama Y, Hiramoto N, Eto T, Ichinohe T, Atsuta Y, Kanda J, Donor/Source Working Group of the Japanese Society for Transplantation and Cellular Therapy.
    Cytotherapy; 2024 Aug 15; 26(8):910-920. PubMed ID: 38639671
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. PBSCT is associated with poorer survival and increased chronic GvHD than BMT in Japanese paediatric patients with acute leukaemia and an HLA-matched sibling donor.
    Shinzato A, Tabuchi K, Atsuta Y, Inoue M, Inagaki J, Yabe H, Koh K, Kato K, Ohta H, Kigasawa H, Kitoh T, Ogawa A, Takahashi Y, Sasahara Y, Kato S, Adachi S.
    Pediatr Blood Cancer; 2013 Sep 15; 60(9):1513-9. PubMed ID: 23512888
    [Abstract] [Full Text] [Related]

  • 8. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase.
    Elmaagacli AH, Runkel K, Steckel N, Opalka B, Trenschel R, Seeber S, Schaefer UW, Beelen DW.
    Bone Marrow Transplant; 2001 Apr 15; 27(8):809-15. PubMed ID: 11477437
    [Abstract] [Full Text] [Related]

  • 9. Comparisons between allogeneic peripheral blood stem cell transplantation and allogeneic bone marrow transplantation in adult hematologic disease: a single center experience.
    Liu YC, Chang CS, Liu TC, Chen TP, Sue YC, Hsiao HH, Lin SF.
    Kaohsiung J Med Sci; 2003 Nov 15; 19(11):541-8. PubMed ID: 14658482
    [Abstract] [Full Text] [Related]

  • 10. Comparative analysis of unrelated cord blood transplantation and HLA-matched sibling hematopoietic stem cell transplantation in children with high-risk or advanced acute leukemia.
    Zheng C, Zhu X, Tang B, Yao W, Song K, Tong J, Geng L, Liu H, Sun Z.
    Ann Hematol; 2015 Mar 15; 94(3):473-80. PubMed ID: 25217231
    [Abstract] [Full Text] [Related]

  • 11. Clinical separation of cGvHD and GvL and better GvHD-free/relapse-free survival (GRFS) after unrelated cord blood transplantation for AML.
    Zheng CC, Zhu XY, Tang BL, Zhang XH, Zhang L, Geng LQ, Liu HL, Sun ZM.
    Bone Marrow Transplant; 2017 Jan 15; 52(1):88-94. PubMed ID: 27376453
    [Abstract] [Full Text] [Related]

  • 12. Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors: results of a single-center study.
    Blau IW, Basara N, Lentini G, Guenzelmann S, Kirsten D, Schmetzer B, Bischoff M, Roemer E, Kiehl MG, Fauser AA.
    Bone Marrow Transplant; 2001 Jan 15; 27(1):27-33. PubMed ID: 11244435
    [Abstract] [Full Text] [Related]

  • 13. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ, Li J, Tan EX, Zhang GC, Wu XY, Peng AH, Zheng D, Zou WY, Hong WD, Luo SK.
    Zhonghua Zhong Liu Za Zhi; 2006 Jul 15; 28(7):545-8. PubMed ID: 17147125
    [Abstract] [Full Text] [Related]

  • 14. Comparison of unrelated cord blood transplantation and HLA-matched sibling hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in advanced stage.
    Zheng C, Tang B, Yao W, Tong J, Zhu X, Song K, Geng L, Liu H, Sun Z.
    Biol Blood Marrow Transplant; 2013 Dec 15; 19(12):1708-12. PubMed ID: 24060407
    [Abstract] [Full Text] [Related]

  • 15. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial.
    Flowers ME, Parker PM, Johnston LJ, Matos AV, Storer B, Bensinger WI, Storb R, Appelbaum FR, Forman SJ, Blume KG, Martin PJ.
    Blood; 2002 Jul 15; 100(2):415-9. PubMed ID: 12091330
    [Abstract] [Full Text] [Related]

  • 16. Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older.
    Konuma T, Tsukada N, Kanda J, Uchida N, Ohno Y, Miyakoshi S, Kanamori H, Hidaka M, Sakura T, Onizuka M, Kobayashi N, Sawa M, Eto T, Matsuhashi Y, Kato K, Ichinohe T, Atsuta Y, Miyamura K, Donor/Source Working Group of the Japan Society for Hematopoietic Cell Transplantation.
    Am J Hematol; 2016 May 15; 91(5):E284-92. PubMed ID: 26910296
    [Abstract] [Full Text] [Related]

  • 17. Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient.
    Spencer A, Szydlo RM, Brookes PA, Kaminski E, Rule S, van Rhee F, Ward KN, Hale G, Waldmann H, Hows JM, Batchelor JR, Goldman JM.
    Blood; 1995 Nov 01; 86(9):3590-7. PubMed ID: 7579468
    [Abstract] [Full Text] [Related]

  • 18. Allogeneic bone marrow transplantation for chronic myeloid leukemia: a single center experience.
    Vela-Ojeda J, Tripp-Villanueva F, Sánchez-Cortés E, Ayala-Sánchez M, Rosas-Cabral A, Esparza MG, García-Chávez J, García-León LD, González-Llaven J.
    Arch Med Res; 2000 Nov 01; 31(2):206-9. PubMed ID: 10880729
    [Abstract] [Full Text] [Related]

  • 19. Children with acute leukemia: a comparison of outcomes from allogeneic blood stem cell and bone marrow transplantation.
    Lin YF, Lairson DR, Chan W, Du XL, Leung KS, Kennedy-Nasser AA, Martinez CA, Heslop HE, Brenner MK, Krance RA.
    Pediatr Blood Cancer; 2011 Jan 01; 56(1):143-51. PubMed ID: 21108446
    [Abstract] [Full Text] [Related]

  • 20. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr 01; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.